These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8702122)

  • 1. Mutations affecting multiple functional domains of FGFR3 cause different skeletal dysplasias: a personal retrospective in honor of John Wasmuth.
    Cohn DH
    Ann N Y Acad Sci; 1996 Jun; 785():160-3. PubMed ID: 8702122
    [No Abstract]   [Full Text] [Related]  

  • 2. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia].
    Rousseau F; Bonaventure J; Le Merrer M; Maroteaux P; Munnich A
    Ann Endocrinol (Paris); 1996; 57(3):153. PubMed ID: 8949408
    [No Abstract]   [Full Text] [Related]  

  • 4. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients.
    Yan-Ling G; Ji-Hong N; Guo-Qiang L; Wei W; De-Fen W
    Horm Res; 1998; 49 Suppl 1():57. PubMed ID: 9554479
    [No Abstract]   [Full Text] [Related]  

  • 5. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.
    Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX
    Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.
    Cohen MM
    Int J Oral Maxillofac Surg; 1998 Dec; 27(6):451-5. PubMed ID: 9869286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.
    Foldynova-Trantirkova S; Wilcox WR; Krejci P
    Hum Mutat; 2012 Jan; 33(1):29-41. PubMed ID: 22045636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene.
    Bellus GA; McIntosh I; Szabo J; Aylsworth A; Kaitila I; Francomano CA
    Ann N Y Acad Sci; 1996 Jun; 785():182-7. PubMed ID: 8702125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
    Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
    Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
    Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
    Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.
    Garofalo S; Kliger-Spatz M; Cooke JL; Wolstin O; Lunstrum GP; Moshkovitz SM; Horton WA; Yayon A
    J Bone Miner Res; 1999 Nov; 14(11):1909-15. PubMed ID: 10571691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association.
    Angle B; Hersh JH; Christensen KM
    Clin Genet; 1998 Nov; 54(5):417-20. PubMed ID: 9842995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia.
    Winterpacht A; Hilbert K; Stelzer C; Schweikardt T; Decker H; Segerer H; Spranger J; Zabel B
    Physiol Genomics; 2000 Jan; 2(1):9-12. PubMed ID: 11015576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
    Bellus GA; Bamshad MJ; Przylepa KA; Dorst J; Lee RR; Hurko O; Jabs EW; Curry CJ; Wilcox WR; Lachman RS; Rimoin DL; Francomano CA
    Am J Med Genet; 1999 Jul; 85(1):53-65. PubMed ID: 10377013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations.
    Brodie SG; Kitoh H; Lachman RS; Nolasco LM; Mekikian PB; Wilcox WR
    Am J Med Genet; 1999 Jun; 84(5):476-80. PubMed ID: 10360402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.
    Iwata T; Li CL; Deng CX; Francomano CA
    Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common FGFR3 gene mutation in hypochondroplasia.
    Prinos P; Costa T; Sommer A; Kilpatrick MW; Tsipouras P
    Hum Mol Genet; 1995 Nov; 4(11):2097-101. PubMed ID: 8589686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia.
    Deutz-Terlouw PP; Losekoot M; Aalfs CM; Hennekam RC; Bakker E
    Hum Mutat; 1998; Suppl 1():S62-5. PubMed ID: 9452043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.